K. Reed

Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease

C. Naranjo, N. Herrmann, K. Lanctôt, 2002, Neuropsychopharmacology.

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers.

C. Naranjo, N. Herrmann, R. Tyndale, 1999, Journal of clinical psychopharmacology.

Paroxetine potentiates the central nervous system side effects of perphenazine: Contribution of cytochrome P4502D6 inhibition in vivo

C. Naranjo, N. Herrmann, E. Sellers, 1997, Clinical pharmacology and therapeutics.

Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.

J. Yarbrough, T. Doherty, S. Cox, 2013, Veterinary journal.

O-12-3 Relationship between D2 receptor occupancy and plasma haloperidol: A pet study

S. Kapur, G. Remington, S. Houle, 1996, European Neuropsychopharmacology.

The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study

S. Kapur, G. Remington, S. Houle, 1997, Psychopharmacology.

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.

C. Naranjo, N. Herrmann, E. Sellers, 1998, Journal of clinical psychopharmacology.

Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.

C. Naranjo, N. Herrmann, E. Sellers, 1998, Journal of clinical psychopharmacology.